Jesse John Francis Clark is an internationally known executive professional, entrepreneur and passionate advocate for people living with Hemophilia and related bleeding disorders. Clark is a serial entrepreneur who is an expert in sales and marketing. Born with severe Hemophilia, Clark founded Hemo Times, a news organization dedicated to providing breaking news to the bleeding disorders community. in 2020, Clark studied gene-editing through Harvard University to better understand how CRISPR could be used to treat genetic diseases. Clark then launched Fixx Pharmaceuticals to develop a cure for Hemophilia and other inherited bleeding disorders.